AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.1974
+0.0053 (2.76%)
At close: Aug 24, 2026, 4:00 PM EDT
0.2067
+0.0093 (4.71%)
After-hours: Aug 24, 2026, 7:30 PM EDT
AEON Biopharma Market Cap
AEON Biopharma has a market cap or net worth of $9.85 million as of August 24, 2026. Its market cap has increased by 9.84% in one year.
Market Cap
9.85M
Enterprise Value
9.19M
1-Year Change
9.84%
Ranking
Category
Stock Price
$0.20
ChartMarket Cap Chart
Since April 12, 2021, AEON Biopharma's market cap has decreased from $63.66M to $9.85M, a decrease of -84.53%. That is a compound annual growth rate of -29.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 9.85M | -24.38% |
| Dec 31, 2025 | 13.02M | -39.67% |
| Dec 31, 2024 | 21.58M | -91.93% |
| Dec 29, 2023 | 267.55M | -80.82% |
| Dec 30, 2022 | 1.40B | 553.24% |
| Dec 30, 2021 | 213.58M | 235.51% |
| Apr 12, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vistagen Therapeutics | 10.83M |
| Theriva Biologics | 10.78M |
| Skye Bioscience | 9.92M |
| Lunai Bioworks | 9.77M |
| OSR Health | 9.73M |
| MetaVia | 9.62M |
| FibroBiologics | 9.59M |
| Imunon | 9.20M |